US Stocks
/
Aligos Therapeutics, Inc. Share Price

Aligos Therapeutics, Inc. Share Price

NASDAQ: ALGS
$0.00
+0.00 (0.00%)
  • Performance
  • Chart
  • Fundamentals
  • Quarterly P&L
  • Annual P&L
  • About
  • Price history
  • FAQs

Aligos Therapeutics, Inc. Stock Performance

Open
N/A
Prev. Close
N/A
Circuit Range
N/A
Day Range
N/A
Year Range
N/A
Volume
N/A
Average Traded
N/A

Aligos Therapeutics, Inc. Share Price Chart

$0.00$0.00
L
Show Current Price
H

Aligos Therapeutics, Inc. Stock Fundamentals & Key Indicators

Market Cap
N/A
PE Ratio (TTM)
N/A
Dividend Yield
0.00%
EPS (TTM)
$-12.16
Revenue (TTM)
$2.19B
Return On Equity (TTM)
-238.24%
Profit Margin
-1104.57%
Debt to Equity
0.00
Quarterly Earnings Growth YoY
95.24%

Aligos Therapeutics, Inc. Quarterly Profit & Loss

All figures in USD

ParticularsSep 2025Dec 2025Mar 2026Jun 2026
Revenue$0.74$0.17$2.83$27.78
Net Profit-$31.54-$19.88-$23.04-$1.50
Net Profit Margin-4262.16%-11694.12%-814.13%-5.40%
Income ChangeN/A36.97%-15.90%93.49%

Aligos Therapeutics, Inc. Annual Profit & Loss

All figures in USD

Particulars2022202320242025
Revenue$13.91$15.53$3.95$2.19
Net Profit-$96.05-$87.68-$131.21-$24.19
Net Profit Margin-690.51%-564.58%-3321.77%-1104.57%
Income ChangeN/A8.71%-49.65%81.56%

About Aligos Therapeutics, Inc.

Aligos Therapeutics Inc is a clinical-stage biotechnology company focused on developing therapeutics for liver diseases and viral infections. Its pipeline includes drug candidates targeting chronic hepatitis B virus (HBV) infection, metabolic dysfunction-associated steatohepatitis (MASH), obesity, and coronavirus infections, with programs such as pefivfoscorvir sodium for HBV, ALG-055009 for MASH and obesity, and ALG-097558 for coronavirus infections.

Aligos Therapeutics, Inc. Historical Returns

MonthOpenCloseChange %

ALGS Share Price FAQs

What is Aligos Therapeutics, Inc. share price today?

chevron-up
Aligos Therapeutics, Inc. share price today is $0.00 as on October 8, 2026 at 4:07 pm IST.

What is the 52 week high and 52 week low of Aligos Therapeutics, Inc. stock?

chevron-up
52 week high/low data for Aligos Therapeutics, Inc. is currently unavailable.

What is ALGS's net income for the last quarter?

chevron-up
ALGS's net income for the last quarter is -1.50B USD.

Can I buy ALGS shares in India?

chevron-up
Yes. You can buy ALGS in India by opening an international trading account.